BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 309446)

  • 1. A metabolite of the 2-nitroimidazole misonidazole with radiosensitizing properties.
    Flockhart IR; Sheldon PW; Stratford IJ; Watts ME
    Int J Radiat Biol Relat Stud Phys Chem Med; 1978 Jul; 34(1):91-4. PubMed ID: 309446
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the toxicity and radiosensitizing ability of misonidazole under conditions of prolonged incubation.
    Wong TW; Whitmore GF; Gulyas S
    Radiat Res; 1978 Sep; 75(3):541-55. PubMed ID: 724984
    [No Abstract]   [Full Text] [Related]  

  • 3. Reduction of misonidazole and its derivatives by xanthine oxidase.
    Josephy PD; Palcic B; Skarsgard LD
    Biochem Pharmacol; 1981 Apr; 30(8):849-53. PubMed ID: 6894696
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytotoxic properties of hydroxylamino- and amino-misonidazole, possible metabolic products of misonidazole, in hypoxic HeLa S3 cells.
    Murayama C; Hori H; Mori T; Inayama S
    Gan; 1983 Oct; 74(5):693-8. PubMed ID: 6642142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative misonidazole metabolism in anaerobic bacteria and hypoxic Chinese hamster lung fibroblast (V-79-473) cells.
    Koch RL; Rose C; Rich TA; Goldman P
    Biochem Pharmacol; 1982 Feb; 31(3):411-4. PubMed ID: 7073768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RSU 1069, a nitroimidazole containing an aziridine group. Bioreduction greatly increases cytotoxicity under hypoxic conditions.
    Stratford IJ; O'Neill P; Sheldon PW; Silver AR; Walling JM; Adams GE
    Biochem Pharmacol; 1986 Jan; 35(1):105-9. PubMed ID: 3753579
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolism and radiosensitization of 4,5-dimethylmisonidazole, a ring-substituted analog of misonidazole.
    Born JL; Smith BR; Harper N; Koch CJ
    Biochem Pharmacol; 1992 Mar; 43(6):1337-44. PubMed ID: 1562284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-enhanced reduction and covalent binding of [2-3H]misonidazole in the perfused rat liver.
    Smith BR
    Biochem Pharmacol; 1984 Apr; 33(8):1379-81. PubMed ID: 6201179
    [No Abstract]   [Full Text] [Related]  

  • 9. Bioreductive metabolism of AF-2[2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide] combined with 2-nitroimidazoles. Implications for use as hypoxic cell markers.
    Koch CJ; Giandomenico AR; Iyengar CW
    Biochem Pharmacol; 1993 Sep; 46(6):1029-36. PubMed ID: 8216345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of hypoxia on the metabolism and excretion of misonidazole by the isolated perfused rat liver--a model system.
    Smith BR; Born JL; Garcia DJ
    Biochem Pharmacol; 1983 May; 32(10):1609-12. PubMed ID: 6860347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of phenytoin, phenobarbital, and ascorbic acid on misonidazole elimination.
    Williams K; Begg E; Wade D; O'Shea K
    Clin Pharmacol Ther; 1983 Mar; 33(3):314-21. PubMed ID: 6825387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the fate of misonidazole (RO 07-0582) and its metabolite desmethylmisonidazole (RO 05-9963), two hypoxic cell radiosensitizers: penetration properties in tumor bearing rats.
    Akel G; Canal P; Mockey E; Vandevoorde E; Laurent F; Soula G
    J Pharmacol; 1983; 14(1):67-77. PubMed ID: 6834852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular localization of radioactively labeled misonidazole in EMT-6-tumor cells in vitro.
    Miller GG; Ngan-Lee J; Chapman JD
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):741-4. PubMed ID: 7107408
    [No Abstract]   [Full Text] [Related]  

  • 14. Modification of the action of misonidazole. III. The effect of diamide on toxicity and radiosensitization.
    Skov KA; Palcic B; Skarsgard LD
    Int J Radiat Biol Relat Stud Phys Chem Med; 1981 Oct; 40(4):335-45. PubMed ID: 6975248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro metabolism of misonidazole.
    Josephy PD; Palcic B; Skarsgard LD
    Br J Cancer; 1981 Apr; 43(4):443-50. PubMed ID: 7236487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of nitroreduction products of misonidazole to nucleic acids and protein.
    Varghese AJ; Whitmore GF
    Cancer Clin Trials; 1980; 3(1):43-6. PubMed ID: 7389036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-mediated nitro-heterocyclic drugs in the radio- and chemotherapy of cancer. An overview.
    Adams GE; Stratford IJ
    Biochem Pharmacol; 1986 Jan; 35(1):71-6. PubMed ID: 2934067
    [No Abstract]   [Full Text] [Related]  

  • 18. Misonidazole-glutathione conjugates in CHO cells.
    Varghese AJ; Whitmore GF
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1341-5. PubMed ID: 6540764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Accumulation Mechanism of 2-Nitroimidazole-based Hypoxia Imaging Probes Revealed by Imaging Mass Spectrometry].
    Shimizu Y
    Yakugaku Zasshi; 2018; 138(11):1345-1352. PubMed ID: 30381642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of heat on the intracellular uptake and radiosensitization of 2-nitroimidazole hypoxic cell sensitizers in vitro.
    Brown DM; Cohen MS; Sagerman RH; Gonzalez-Mendez R; Hahn GM; Brown JM
    Cancer Res; 1983 Jul; 43(7):3138-42. PubMed ID: 6850622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.